跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
瑞宁得 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Anastrozole Tablets
Approved
化学药品
Anastrozole Tablets
ASTRAZENECA UK LIMITED
🇨🇳 National Medical Products Administration
Approval Date
Dec 4, 2023
Approval ID
8ajBfGHMzlj
Company
ASTRAZENECA UK LIMITED
Type
化学药品
Approval Details
Approval Id
8ajBfGHMzlj
Approval Number
国药准字HJ20140692
Generic Name
阿那曲唑片
Generic Name En
Anastrozole Tablets
Trade Name
瑞宁得
Drug Type
化学药品
Dosage Form
片剂
Strength
1mg
Reg Date
2023-12-04
Expired Date
2028-12-03
Company Name
ASTRAZENECA UK LIMITED
Production Company Name
ASTRAZENECA PHARMACEUTICALS LP
Company Detail Path
/organization/astrazeneca-uk-limited
Production Company Detail Path
/organization/astrazeneca-pharmaceuticals-lp
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Dec 4, 2023
Approval ID
8ajBfGHMzlj
Type
化学药品
Back to NMPA Approvals